Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nagane

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|October 11, 1996
Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathwayS A Prigent, M Nagane, H Lin, et al.
Toxics|December 24, 2025
Comprehensive In Vitro Safety Assessment of <i>Acorus calamus</i> Rhizome Oil Using OECD-Compliant New Approach Methods: Classification as a GHS Category 1B Sensitiser and Category 2 IrritantKarishma R Desai, Jay R Ranade, Rajendra M Nagane, et al.
Heliyon|December 10, 2024
Assessing the mutagenic potential of methyl phenlactonoate 3 and Nijmegen-1 in bacterial reverse mutation assaysMuhammad Jamil, Jian You Wang, Kinjal A Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factorS Y Cheng, H J Huang, M Nagane, et al.
Oncogene|December 6, 2011
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathwayR Bonavia, M M Inda, S Vandenberg, et al.
The Journal of Biological Chemistry|January 31, 1997
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signalingH S Huang, M Nagane, C K Klingbeil, et al.
Advances in Experimental Medicine and Biology|August 16, 2016
Skeletal Muscle Oxygenation Measured by EPR Oximetry Using a Highly Sensitive Polymer-Encapsulated Paramagnetic SensorH Hou, N Khan, M Nagane, et al.
Cancer Research|December 4, 2001
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sitesP Guo, L Xu, S Pan, et al.
Neuropathology and Applied Neurobiology|June 11, 2019
Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significanceH Takami, S Fukushima, K Aoki, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Biological Chemistry|October 11, 1996
Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathwayS A Prigent, M Nagane, H Lin, et al.
Toxics|December 24, 2025
Comprehensive In Vitro Safety Assessment of <i>Acorus calamus</i> Rhizome Oil Using OECD-Compliant New Approach Methods: Classification as a GHS Category 1B Sensitiser and Category 2 IrritantKarishma R Desai, Jay R Ranade, Rajendra M Nagane, et al.
Heliyon|December 10, 2024
Assessing the mutagenic potential of methyl phenlactonoate 3 and Nijmegen-1 in bacterial reverse mutation assaysMuhammad Jamil, Jian You Wang, Kinjal A Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factorS Y Cheng, H J Huang, M Nagane, et al.
Oncogene|December 6, 2011
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathwayR Bonavia, M M Inda, S Vandenberg, et al.
The Journal of Biological Chemistry|January 31, 1997
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signalingH S Huang, M Nagane, C K Klingbeil, et al.
Advances in Experimental Medicine and Biology|August 16, 2016
Skeletal Muscle Oxygenation Measured by EPR Oximetry Using a Highly Sensitive Polymer-Encapsulated Paramagnetic SensorH Hou, N Khan, M Nagane, et al.
Cancer Research|December 4, 2001
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sitesP Guo, L Xu, S Pan, et al.
Neuropathology and Applied Neurobiology|June 11, 2019
Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significanceH Takami, S Fukushima, K Aoki, et al.
Pageof 4